Skip to content
Thursday, March 13, 2025
GLP-1 Watch
All the latest news and updates about GLP-1 Drugs
Search
Search
Privacy Policy
The Evolving Landscape of GLP-1 Drugs: Innovations, Market Trends, and Health Implications
Home
2025
March
2
Medigene and EpimAb to develop T cell engagers for solid tumours
GLP-1 News
Medigene and EpimAb to develop T cell engagers for solid tumours
March 2, 2025
admin
Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell engagers (TCR-TCEs).
Post navigation
FDA accepts Sobi’s Gamifant application for HLH/MAS treatment
As diabetes drives up Kentuckians’ use of weight-loss drugs, worries arise about unintended effects – LINK nky